Skip to main content

Table 1 Demographics

From: Costs of illness in amyotrophic lateral sclerosis (ALS): a cross-sectional survey in Germany

 

Percent or median (IQR)

Absolute number of patients

Age, y

65 (17)

 

Sex, female

39.7

62

BMI

24.03 (5.12)

 

Type of health insurance (n = 150), statutory

82.7

124

Symptom onset, y

62 (17.8)

 

Disease duration from symptom onset, y

2 (3)

 

Inherited ALS

3.8

6

ALSFRS-R score (max. 48)

30 (16)

 

King’s staging

 1

12.8

20

 2

26.3

41

 3

28.2

44

 4A

10.3

16

 4B

22.4

35

Level of care (n = 146)

 none

24.7

36

 1

2.1

3

 2

11.6

17

 3

28.1

41

 4

17.1

25

 5

16.4

24

 Self-rated impairment in daily activities

95.5

149

 Permanent attendance of a caregiver necessary

39.1

61

Main caregiver (n = 136)

 Partner

86

117

 Children

7.4

10

 Others

6.6

9

Employment situation of the main caregiver (n = 119)

 Working caregiver

47.1

56

 Main caregiver stopped working because of patient’s ALS

5

6

 Change of weekly working time because of patient’s ALS

14.3

17

 Job change because of patient’s ALS

2.5

3

Drop in salary because of patient’s ALS

10.1

12

Housing situation (n = 152)

 Family

87.5

133

 Alone

10.5

16

 Assisted living/foster home

2

3

Employment (n = 145)

 Employment no longer possible

26.2

38

 Working

13.8

20

 Retired, unemployed, homemaker

60

87

Reasons for unemployability (n = 34)

 Retired because of ALS

61.8

21

 Unable to work

5.9

2

 Unknown

32.4

11

 EQ-VAS score (max. 100)

40 (35)

 

 EQ-5D-5L™ index value (max. 1)

0.585 (0.623)

 
  1. This table shows the most important patient characteristics, their disease stage (King’s staging), and the impairment in their autonomy and working lives. The professional activity assessment of patients and of their main caregivers served as basis for the calculation of indirect costs
  2. Abbreviations: IQR interquartile range, y years, BMI body mass index, n number, ALS amyotrophic lateral sclerosis, ALSFRS-R Revised Amyotrophic Lateral Sclerosis Functional Rating Scale, EQ-VAS score Self-rated health on the visual analogue scale of EuroQol Group EQ-5D-5LTM instrument. health on a visual analogue scale (0–100)